Sponsored By

Bausch & Lomb Withdraws Eye Supplement Lawsuit 34568Bausch & Lomb Withdraws Eye Supplement Lawsuit

March 28, 2005

1 Min Read
Bausch & Lomb Withdraws Eye Supplement Lawsuit

Bausch & Lomb Withdraws Eye Supplement Lawsuit


Bausch &Lomb (B&L) withdrew the lawsuit it filed in U.S. District Court on May 8,which originally alleged Waltham, Mass.-based Inverness Medical Innovations andits subsidiary, Freehold, N.J.-based IVC Industries, manufacture and distributevitamin supplements that infringe upon patent rights tied to the formula behindB&Ls Ocuvite® PreserVision eye supplements. According to B&L, itreceived notification from Inverness declaring neither it nor IVC distribute ormanufacture certain eye private label eye supplements that infringe upon thepatent rights. B&L noted the dispute was quickly clarified due to a thoroughinternal review and prompt, direct communication by Inverness.

B&L developed the formula in conjunction with the NationalEye Institute (NEI) and holds worldwide patent rights under a license agreementwith the National Institutes of Health (NIH). The landmark NEI Age-Related EyeDisease Study (AREDS) showed supplementation with antioxidant vitamins (C, E andbeta-carotene) plus zinc (as supplied by B&L) lowered risk of age-relatedmacular degeneration (AMD) and its associated vision loss, but had no effect ondevelopment or progression of cataract (Arch Ophthamol.119:1417-36, 2001).

Inverness (www.invernessmedical.com) and IVC offer OptiZincand Eye Vitamin plus Lutein in their private label manufacturing line.

Subscribe and receive the latest insights on the healthy food and beverage industry.
Join 47,000+ members. Yes, it's completely free.

You May Also Like